Boston Scientific

...in Piper Jaffray Health Care Conference NATICK, Mass., Nov. 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, December 1-2. Ray...

In this article: Piper Jaffray, NYSE, and Massachusetts

...Street will pay particularly close attention to sales of heart rhythm devices, following weaker-than-expected sales by competitors Boston Scientific Corp. and St. Jude Medical. St. Jude saw sales decline, while Boston Scientific seemed to...

In this article: Medtronic, Revenue, Boston Scientific Corp., Food and Drug Administration, Thomson Reuters, St. Jude Medical, Wall Street, Washington, and Minnesota

...possibly pulling a permit to protest, but he wasnaEUR™t clear whether that ever happened. A call to Boston Scientific seeking comment was not returned. The company purchased the building, built in 1972, in 2003 for $29.5 million. The...

In this article: Boston Scientific Corp., South Florida Business Journal, and Costa Rica

...discuss the closure. In 2004, the Beacon Council announced plans to give up to $360,000 in tax refunds to Boston Scientific to help the company expand its plant. But no money was paid when the Beacon Council learned the company would expand...

In this article: Johnson & Johnson, Miami-Dade, Miami Lakes, Tax, Venture capital, and University of Miami

...thing when we're trying to promote a cluster in life sciences and you lose a company like Boston Scientific," Nero said. "It's just not good. " Boston Scientific didn't return calls for comment yesterday. The company makes medical devices...

In this article: Miami-Dade, Florida, World Wide Web, The Miami Herald, Natick, and Doral, Fla

BY SCOTT ANDRON Medical-products manufacturer Boston Scientific will close its plant in Doral, eliminating 1,400 jobs by 2011, Miami-Dade economic development officials announced Friday afternoon. The company is transferring the plant's...

In this article: Surgery, The Miami Herald, and Costa Rica

Friday, November 20, 2009, 1:26pm EST Boston Scientific gets marketing OK for esophageal stent Boston Scientific Corp. said it received approvals in the United States and Europe to market its WallFlex esophageal stent. The...

In this article: Boston Scientific Corp., Esophageal cancer, NYSE, U.S. Food and Drug Administration, Natick, Europe, and United States

...gynecologic conditions through the integration of clinical practice, research, innovation, and dialogue. About Boston Scientific Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are...

In this article: Surgery, Menorrhagia, Urinary incontinence, Medical advice, and American Association

THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING Boston Scientific Corp. yesterday said it has agreed to pay $296 million to settle a US Department of Justice investigation into charges that its Guidant heart-device subsidiary made faulty...

In this article: Boston Scientific Corp., Guidant Corp., US Department Of Justice, New York, and Business operations

...to failure to include information in reports to the U.S. Food and Drug Administration, along with Boston Scientific's payment. Natick, Mass. Boston Scientific Corp. updated its third-quarter profit results to reflect the charge. We...

In this article: Guidant, Misdemeanor, U.S. Food and Drug Administration, Department of Justice, and Natick, Mass.